SynthesisNutrition and health2026
Prognostic impact of weight loss during radiation therapy in patients with head and neck cancer: A systematic review.
Synthesis in Nutrition and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundMalnutrition and weight loss (WL) are frequent in patients with head and neck cancer (HNC) during radiotherapy (RT), affecting treatment tolerance and outcomes. Nutritional interventions aim to minimize WL and support therapy completion, yet the prognostic value of WL during RT remains unclear.Aims/ObjectivesTo systematically evaluate the prognostic impact of WL before, during and after RT in patients with HNC.Methods/MethodologyThis systematic review included studies from 2012 involving adult patients treated with definitive or postoperative RT for HNC, studies were eligible if WL/body mass index (BMI) change was analysed versus survival outcomes (overall survival (OS), disease-specific survival (DSS)/cancer-specific survival, disease-free survival (DFS)). A structured PubMed and Cochrane search was conducted and results were synthesized narratively.Results/FindingsEight studies met the inclusion criteria. Pretreatment WL > 10% consistently predicted inferior OS and disease-specific survival (DSS). WL during RT varied widely between studies: most reported no association with OS, whereas single studies reported worse DSS with critical WL, worse OS with ΔBMI >1 kg/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.